Using the same proprietary platform technology used to produce our embryonic mouse cell line, we have created of a series of Rat hypothalamic neurons immortalized from rat embryonic day 18 hypothalamic primary cultures. The resulting 22 phenotypically distinct cell lines have been screening for over 25 different neuropeptides, enzymatic markers and biologically active receptors. Please click here for further details.

Download the new CELLutions Biosytems’ flyer which includes descriptions and characterization data for all of the cell lines currently available.

To request a hardcopy, please This e-mail address is being protected from spam bots, you need JavaScript enabled to view it .

CEDARLANE announced the acquisition of CELLutions Biosystems Inc. to create a powerful combination in the Canadian biotechnology industry.

“This is a very exciting development for these two important players (in the Life Science research community),” says Dr. Tim McTiernan, Assistant Vice-President of Research and Executive Director of The Innovations Group, University of Toronto. “CEDARLANE’s acquisition of CELLutions means the development of sound and sustainable products to aid in the understanding of complex human diseases and to assist in the development of new and effective treatments.”

“CELLutions is on its way to becoming a leading distributor of cell lines and other biological tools for the research and development market,” says Cynthia Greer, President of CEDARLANE. “As an established, leading manufacturer and distributor, we can maximize CELLutions’ potential, and work together to find solutions to important health issues facing Canadians and people worldwide.”